Reig Jofre History:
1929 Foundation in Barcelona (Spain) by the pharmacist Ramon Reig Jofre. The current CEO is the third generation of the Reig family.
1964-1999 Creation of a portfolio of prescription and OTC products in dermatology and respiratory through the combination of own developments and various acquisitions in Spain
1978-2009 Specialization in sterile injectables
1978 First freeze dryer
1998 Acquisition of Sant Joan Despí plant
2009 New vial plant
2000-2004 Antibiotic specialization
2000 acquisition of the Toledo plant
2003 Construction of the Cephalosporin plant
2004 Acquisition of antibiotic licenses Anaclosil, Pulmictan, Ardine, and ArdineClav
2015 Reig Jofre merges with the company Natraceutical, a benchmark in Europe in the sector of nutritional supplements for sale in pharmacies through its Forté Pharma brand and becomes the 5th Spanish pharmaceutical company by turnover, listed on the Spanish stock market
2019 Acquisition of the Joint Health and Pain product portfolio from Bioiberica company.
Collaboration agreements in the development of new products.
Market entry in South Korea with the injectable for hospital use Remifentanil.
Reig Jofre products are available in 130 countries.